RxDoctor Payments Data

Danny Martin

Internal Medicine · Florence, ALNPI 1184676884

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.2% of the total across 332 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,722 and has fallen 90.3% since, to $167 in 2022.

$4,651in general payments, 2019–2025

Across 332 payments — averaging $14.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$871
  • AstraZeneca$708
  • Pfizer$510
  • Boehringer Ingelheim$392
  • GSK$368
  • Amarin Pharma, Inc.$346
  • plus $1K from 16 others

What the payments were for

  • Speaking & faculty fees$702%
  • Food & beverage$4,56998%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,651 in reported general payments places this provider in the 85th percentile of 1,533 internal medicine providers in Alabama.

See all internal medicine providers in Alabama →

Other internal medicine in Florence

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →